Early Versus Late Periprosthetic Joint Infection After Total Knee Arthroplasty: Do Patient Differences Exist?

IF 3.4 2区 医学 Q1 ORTHOPEDICS
{"title":"Early Versus Late Periprosthetic Joint Infection After Total Knee Arthroplasty: Do Patient Differences Exist?","authors":"","doi":"10.1016/j.arth.2024.04.061","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Periprosthetic joint infection (PJI) is a devastating complication following total knee arthroplasty (TKA). Little evidence exists comparing those with early versus late PJI. The purpose of the study was to determine comorbidity profile differences between patients developing early and late PJI.</p></div><div><h3>Methods</h3><p>There were 72,659 patients undergoing primary TKA from 2009 to 2021, who were identified from a commercial claims and encounters database. Subjects diagnosed with PJI were categorized as either ‘early’ (within 90 days of index procedure) or ‘late’ (&gt; 2 years after index arthroplasty). Non-infected patients within these periods served as control groups following 4:1 propensity score matching on other extraneous variables. Logistic regression analyses were performed comparing comorbidities between groups.</p></div><div><h3>Results</h3><p>Patients were significantly younger in the late compared to the early infection group (58.1 versus 62.4 years, <em>P</em> &lt; .001). When compared to those with early PJI, patients who had chronic kidney disease (13.3 versus 4.1%; OR [odds ratio] 5.17, <em>P</em> = .002), malignancy (20.4 versus 10.5%; OR 2.53, <em>P</em> = .009), uncomplicated diabetes (40.8 versus 30.6%; OR 2.00, <em>P</em> = .01), rheumatoid arthritis (9.2 versus 3.3%; OR 2.66, <em>P</em> = .046), and hypertension (88.8 versus 81.6%; OR 2.17, <em>P</em> = .04), were all significant predictors of developing a late PJI.</p></div><div><h3>Conclusions</h3><p>When compared to patients diagnosed with early PJI following primary TKA, the presence of chronic kidney disease, malignancy, uncomplicated diabetes, rheumatoid arthritis, and hypertension, were independent risk factors for the development of late PJI. Younger patients who have these comorbidities may be targets for preoperative optimization interventions that minimize the risk of PJI.</p></div>","PeriodicalId":51077,"journal":{"name":"Journal of Arthroplasty","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S088354032400384X/pdfft?md5=6c89667ad56dd683263fd16769d1a342&pid=1-s2.0-S088354032400384X-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Arthroplasty","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S088354032400384X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Periprosthetic joint infection (PJI) is a devastating complication following total knee arthroplasty (TKA). Little evidence exists comparing those with early versus late PJI. The purpose of the study was to determine comorbidity profile differences between patients developing early and late PJI.

Methods

There were 72,659 patients undergoing primary TKA from 2009 to 2021, who were identified from a commercial claims and encounters database. Subjects diagnosed with PJI were categorized as either ‘early’ (within 90 days of index procedure) or ‘late’ (> 2 years after index arthroplasty). Non-infected patients within these periods served as control groups following 4:1 propensity score matching on other extraneous variables. Logistic regression analyses were performed comparing comorbidities between groups.

Results

Patients were significantly younger in the late compared to the early infection group (58.1 versus 62.4 years, P < .001). When compared to those with early PJI, patients who had chronic kidney disease (13.3 versus 4.1%; OR [odds ratio] 5.17, P = .002), malignancy (20.4 versus 10.5%; OR 2.53, P = .009), uncomplicated diabetes (40.8 versus 30.6%; OR 2.00, P = .01), rheumatoid arthritis (9.2 versus 3.3%; OR 2.66, P = .046), and hypertension (88.8 versus 81.6%; OR 2.17, P = .04), were all significant predictors of developing a late PJI.

Conclusions

When compared to patients diagnosed with early PJI following primary TKA, the presence of chronic kidney disease, malignancy, uncomplicated diabetes, rheumatoid arthritis, and hypertension, were independent risk factors for the development of late PJI. Younger patients who have these comorbidities may be targets for preoperative optimization interventions that minimize the risk of PJI.

全膝关节置换术后早期与晚期假体周围感染:患者是否存在差异?
背景假体关节感染(PJI)是全膝关节置换术(TKA)后的一种严重并发症。目前几乎没有证据显示早期和晚期 PJI 患者之间存在差异。本研究旨在确定早期和晚期 PJI 患者的合并症特征差异。方法2009 年至 2021 年期间,72,659 名患者接受了初级 TKA 手术,这些患者是从商业索赔和病例数据库中识别出来的。确诊为 PJI 的受试者被分为 "早期"(指数手术后 90 天内)或 "晚期"(指数关节成形术后 2 年)。在这些时间段内的非感染患者作为对照组,根据其他无关变量进行 4:1 倾向评分匹配。结果与早期感染组相比,晚期感染组患者明显更年轻(58.1 岁对 62.4 岁,P < .001)。与早期 PJI 患者相比,患有慢性肾病(13.3% 对 4.1%;OR[几率比] 5.17,P = .002)、恶性肿瘤(20.4% 对 10.5%;OR 2.53,P = .009)、无并发症糖尿病(40.8% 对 30.6%;OR 2.00,P = .01)、类风湿性关节炎(9.2% 对 3.3%;OR 2.66,P = .046)和高血压(88.8% 对 81.结论与原发性 TKA 术后诊断为早期 PJI 的患者相比,存在慢性肾病、恶性肿瘤、无并发症糖尿病、类风湿性关节炎和高血压是发生晚期 PJI 的独立危险因素。有这些合并症的年轻患者可能是术前优化干预的目标,以最大限度地降低 PJI 风险。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Arthroplasty
Journal of Arthroplasty 医学-整形外科
CiteScore
7.00
自引率
20.00%
发文量
734
审稿时长
48 days
期刊介绍: The Journal of Arthroplasty brings together the clinical and scientific foundations for joint replacement. This peer-reviewed journal publishes original research and manuscripts of the highest quality from all areas relating to joint replacement or the treatment of its complications, including those dealing with clinical series and experience, prosthetic design, biomechanics, biomaterials, metallurgy, biologic response to arthroplasty materials in vivo and in vitro.
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信